Andrea Schietinger is an assistant professor and Cancer Immunologist at the Memorial Sloan Kettering Cancer Center. She investigates immune responses to cancer, molecular mechanisms underlying tumor-induced T cell dysfunction, and new approaches for cancer immunotherapy. Schietinger’s laboratory investigates the regulatory mechanisms of T cell dysfunction in the context of tumors. They use transgenic mouse models to understand how T cell unresponsiveness in tumor-reactive T cells is molecularly and epigenetically regulated, to design strategies to override cell-intrinsic T cell dysfunction programs to improve cancer immunotherapy, and to ultimately validate the findings and insights in human cancers through collaborations with clinical investigators.
Education & Training
- University of Hamburg, Germany, PharmD
- University of Chicago, Chicago, IL, PhD
- University of Munich, Germany, PhD